New insider activity at Bio Green Med Solution ( (BGMS) ) has taken place on October 14, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
FITTERS Diversified Berhad, a significant shareholder, has sold 51,400 shares of Bio Green Med Solution stock, amounting to a total sale value of $269,850.
Recent Updates on BGMS stock
In recent developments, Bio Green Med Solution (BGMS) has made significant moves that could impact its stock performance. On October 6, 2025, the company finalized an Asset Purchase Agreement with Tethra Biosciences Inc., selling assets including patent rights for Plogosertib, a PLK 1 inhibitor, for $300,000 with a potential milestone payment of $170,000. This strategic shift may influence its market positioning by transferring key intellectual property. Additionally, on October 7, 2025, BGMS announced a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock, payable on November 1, 2025. Despite these developments, Spark, TipRanks’ AI Analyst, maintains an ‘Underperform’ rating for BGMS, citing financial strain, operational inefficiencies, and unattractive valuation metrics such as a negative P/E ratio and lack of dividend yield. Furthermore, the company received a Nasdaq notice on September 11, 2025, for not meeting the minimum Market Value of Publicly Held Shares requirement, with a deadline to regain compliance by March 10, 2026.
Spark’s Take on BGMS Stock
According to Spark, TipRanks’ AI Analyst, BGMS is a Underperform.
Cyclacel Pharmaceuticals is currently under significant financial strain, marked by operational inefficiencies and a weak financial position, as reflected in its low financial performance score. While the technical indicators suggest a neutral trend, the valuation is unattractive due to its negative P/E ratio and lack of dividend yield. These factors collectively result in a low overall stock score.
To see Spark’s full report on BGMS stock, click here.
More about Bio Green Med Solution
YTD Price Performance: -93.41%
Average Trading Volume: 1,852,141
Technical Sentiment Signal: Strong Sell
Current Market Cap: $11.49M